BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 15313816)

  • 1. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
    Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Dermatol Surg; 2005 Jan; 31(1):38-42; discussion 42. PubMed ID: 15720094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma in Turkey.
    Tiftikcioğlu YO; Karaaslan O; Aksoy HM; Aksoy B; Koçer U
    J Dermatol; 2006 Feb; 33(2):91-5. PubMed ID: 16556274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
    Gibson GE; Ahmed I
    J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of basosquamous carcinoma after Mohs micrographic surgery.
    Skaria AM
    Dermatology; 2010; 221(4):352-5. PubMed ID: 20924160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
    Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
    Aoyagi S; Nouri K
    Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.